# COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE

> **NIH NIH N01** · DUKE UNIVERSITY · 2020 · $20,980,989

## Abstract

To provide expertise and state-of-the-art approaches to manufacture, formulate, optimize, and evaluate the safety and toxicity of innovative, cutting-edge influenza vaccine platforms and approaches.

## Key facts

- **NIH application ID:** 10192488
- **Project number:** 75N93019C00053-P00002-9999-1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** MATTHEW JOHNSON
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $20,980,989
- **Award type:** —
- **Project period:** 2019-08-26 → 2024-02-25

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10192488

## Citation

> US National Institutes of Health, RePORTER application 10192488, COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE (75N93019C00053-P00002-9999-1). Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/grant/nih/10192488. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*